EMR vs PATH · P/E 34, rev $4.86B vs P/E 19, rev $1.61B
Emerson Electric Company (EMR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the EMR and PATH stock pages for the full models.
Not investment advice.